ONCO.IO

ONCO.IO is an integrative resource for microrna and transcription factors analysis in cancer.

Network analysis tools Build network by filter


Database is updated every day
last update: MIR31=>RASA2, 2019-07-23 08:16:57 by rhizoman1

ONCO.IO statistics

Total number of interactions:
16344

binding of miRNA:
6391

transcription regulation:
4594

drug interactions:
454

chemo/drugresistance:
211

metabolic reactions:
8244

TF => ncRNA reactions:
737

drug => gene/miR reactions:
454
Path. processes associations:
15260

Diseases associations:
9473

Pubmeds:
18190

Express.levels associations:
4000

Prognosis associations:
1884

Diagnosis associations:
52

Biomarker localization:
5128

Cell lines associations:
17974

Tumor stage associations:
55

Methods associations:
50200

Cell Localization:
412
number of new added interactions:
for last week:
45
(
+2
)
for last 2 weeks:
88

for last month:
206 (
-25
)

for last two month:
437

graph view
top annotators of last month:
rhizoman1:
205
(
-26
)
Вася:
1
(
+1
)

Last added links: MIR31=>RASA2 MIR934=>BRMS1L MIR299=>TCF7L2 MIR215=>SOX9 ZFAS1=>MIR135A1


Long non-coding RNA interactions page

ONCO.IO is an integrated knowledge database and network analysis tool for exploring complex gene regulatory networks involved in cancer.

ONCO.IO database content is based on the manually curated annotation of experimentally verified molecular interactions described in the literature and includes microRNAs, lncRNAs, mRNAs, signaling proteins and transcription factors interactions.

Key features:


Search term and build network:


Processes

Pathogenic process (PP) - molecular, cellular or tissue malfunction determining initiation, development and outcome of disease. Full list of PP is here
Interactions (or edges) are associated with pathogenic process and can influence as positively and negatively on the process.

Processes:

Diseases

Diseases:

Genes and ncRNAs

Symbol:

Or use more complex filters.

News:

miRs in prostate cancer: comlex regulatory connections with cancer hallmarks 18 January 2019 23:53:17 by Rhizoman1
Next week we will annotate regulatory interactions in prostate cancer. Prostate cancer (PCa) is considered the most prevalent malignancy and the second major cause of cancer-related death in males from Western countries. Androgen deprivation therapy (ADT) is the primary treatment option for male patients with advanced symptomatic PCa. Castration-resistant prostate cancer (CRPC) refers to the continuous progression of PCa following ADT. We will focus on the role of non-coding RNAs and transcription factors in prostate cancer development and progression.
Paywall: The Business of Scholarship 26 December 2018 16:17:32 by Sasha Fokin
Paywall: The Business of Scholarship is a documentary which focuses on the need for open access to research and science, questions the rationale behind the $25.2 billion a year that flows into for-profit academic publishers, examines the 35-40% profit margin associated with the top academic publisher Elsevier and looks at how that profit margin is often greater than some of the most profitable tech companies like Apple, Facebook and Google.

Paywall: The Business of Scholarship (Full Movie) CC BY 4.0 from Paywall The Movie on Vimeo.

The program of reduce the critical dependence of Russian science on foreign genetic and biological databases. 26 December 2018 16:10:04 by Sasha Fokin
"The Ministry of Education and Science proposes to allocate 220.5 billion rubles. on the development of genetic technologies in the framework of the federal scientific and technical program for the years 2019-2027. This is stated in the draft government decree on the approval of the program, published on Friday on the federal portal of draft regulations. The implementation of the program is designed to "reduce the critical dependence of Russian science on foreign genetic and biological data bases, foreign specialized software and devices, the programs passport says. In Russia, bioinformatics and genetic databases, basic reagents and software products and equipment prototypes should be created." The leading scientific organization will be the Kurchatov Institute. The ONCO.IO is made entirely by our forces and means without the help of any other structures and organizations. This is a completely independent product. For all inhabitants of the planet Earth, we provide equal access to ONCO.IO and his services.
Immune response interactome! 06 October 2018 01:24:29 by Rhizoman1
T-cell-DC, signaling and regulatory pathways that develop immune response. Co-regulatory and repressor molecules. Receptors, signaling molecules, transcription factors as are drivers of anti-cancer immunity. Next week we will annotate immunoregulatory interactome! This is dedicated to the Nobel prize in Physiology or Medicine 2018!
Hooray! Today our database reached the milestone of 15,000 manualy curated validated links 27 September 2018 15:33:44 by Sasha Fokin

NRF2 and TRIM proteins , where is conection? 17 September 2018 00:15:16 by Rhizoman1
In addition to NRF2 interactome we will integrate TRIM proteins interactome! TRIM (Tripartite motif (TRIM) proteins) are a versatile family of ubiquitin E3 ligases involved in a multitude of cellular processes. Oxidative stress and aniviral response)
NRF2 is a key transcription factor for cancer biology 12 September 2018 15:15:14 by Rhizoman1
This week we are planning to annotate NRF2 interactome. It will include NRF2 direct transcriptional targets and upstream regulatory interactions. Now in ONCO.IO contains only 53 interactions!
Blog

Last saved networks:

gene_network__400_genes_1506_links [19 July 2019 14:15:43 by guest ]
gene_network__400_genes_1506_links [19 July 2019 14:11:15 by guest ]
tt22_6 [19 July 2019 13:35:13 by guest ]
tt22_4 [19 July 2019 13:22:35 by guest ]
tt22_3 [18 July 2019 21:34:52 by guest ]
tt22_1 [18 July 2019 21:08:43 by guest ]
[18 July 2019 20:00:07 by guest ]
tt1 [18 July 2019 19:14:36 by guest ]
mirnanet [08 July 2019 14:00:59 by guest ]
RELA [29 June 2019 12:36:02 by guest ]
lncRNA_reg_test1 [23 June 2019 15:29:15 by guest ]
HOTAIR, MALAT1, XIST lncRNA, long non-coding RNAs [22 June 2019 20:43:38 by guest ]
lncRNA_miR_sub1 [22 June 2019 13:29:50 by guest ]
mir199a2 [12 June 2019 18:55:58 by guest ]
mir199a2 [12 June 2019 18:54:07 by guest ]
mir29 [12 June 2019 17:29:19 by guest ]
breast cancer [29 May 2019 19:10:29 by guest ] breast cancer
Tongue Tumor 29 Selected mRna [29 May 2019 18:16:41 by guest ]
filters test [28 May 2019 23:13:29 by Sasha Fokin ]
filters test [28 May 2019 23:13:23 by Sasha Fokin ]
filters test [28 May 2019 23:13:14 by Sasha Fokin ]
myc nkx3-1 [28 May 2019 20:53:22 by guest ]
mir NETWORK [28 May 2019 17:47:05 by guest ]
metabol_regulator_1 [27 May 2019 17:54:40 by guest ] https://onco.io/metabolytes_proteins.
metabol regulator [27 May 2019 17:28:30 by guest ]
metabol regulator [27 May 2019 17:15:56 by guest ]
metabol test 2 [27 May 2019 15:45:56 by guest ]
oncoB 1. [15 May 2019 17:12:08 by guest ]
miR-215 [12 May 2019 14:21:07 by guest ]
service 56_top 7 plasma microRNAs [15 April 2019 18:33:16 by guest ]
network_1554884861 [10 April 2019 13:27:41 by guest ]
miRNA_Chip [09 April 2019 15:54:03 by guest ]
shortest_path example [05 March 2019 14:48:01 by guest ]
downstream [17 February 2019 12:51:23 by guest ]
miR-100_miR154_regulatory network [10 February 2019 20:26:37 by guest ]
CCL4 mouse miRNA [08 February 2019 14:11:42 by Sasha Fokin ]
miR-100_miR154_regulatory network [05 February 2019 14:24:53 by guest ]
miR100_miR154 [05 February 2019 14:07:12 by guest ]
network_1548816960 [30 January 2019 06:56:01 by imilia@unisza.edu.my ]
obesity_discovery_spill over microRNAs [23 January 2019 23:28:03 by guest ]
All saved networks

Donate:

Bitcoin:

Coming soon:


Metabolites

Pubmeds

Drugs

Interactions

Mutations

Educational game